Linde (LIN) Stock News Today: Analyst Forecasts, Price Targets and What Investors Are Watching (Dec. 14, 2025)
14 December 2025
5 mins read

Linde (LIN) Stock News Today: Analyst Forecasts, Price Targets and What Investors Are Watching (Dec. 14, 2025)

Linde plc is ending 2025 with a familiar mix of “defensive quality” and macro sensitivity: resilient margins and cash generation on one hand, and a still-soft industrial backdrop—especially in Europe—on the other. The latest cluster of coverage (as of December 14, 2025) is dominated by analyst updates following Linde’s recent investor engagement, plus a handful of regulatory filings and insider activity that have kept the stock in focus. Investing.com

Below is a comprehensive roundup of the current news, forecasts, and analyst takes shaping sentiment around Linde stock right now.


Linde stock price check (as of Dec. 14, 2025)

With U.S. markets closed on Sunday, the most recent actionable reference point is Friday’s close:

  • Last close (Fri., Dec. 12, 2025): $416.24
  • Recent move: Linde has rebounded sharply off early-week levels (it traded below $390 earlier in the week before the late-week rally).
  • A frequently cited context point in this week’s analyst notes: the stock has been trading well below its 52‑week high near $486, after a valuation “reset” into year-end. Investing.com UK

What’s driving the latest Linde stock coverage on Dec. 14, 2025

1) A wave of analyst updates after the investor meeting

The biggest “fresh” theme in Linde coverage is analyst commentary following investor sessions—and the tone is broadly constructive, even where firms trimmed targets.

Key calls circulating in the last several days include:

  • UBS: Buy, $500 target — UBS reiterated Buy after an investor event, arguing Linde can sustain 10%+ longer-term EPS growth based on its “EPS growth algorithm” (management actions + capital allocation), with macro conditions potentially adding upside if industrial production improves. Investing.com UK
  • RBC Capital: Outperform, target cut to $490 (from $540) — RBC kept Outperform but lowered its target, citing macro concerns and also trimming its modeled FY2026/FY2027 EPS expectations following the company’s annual investor meeting in Connecticut.
  • Evercore ISI: Outperform, $490 target — Evercore framed the selloff as a rare “valuation reset,” emphasizing Linde’s project pipeline/backlog and highlighting a set of large projects expected to ramp in 2026. Investing.com UK
  • Deutsche Bank: Buy, $495 target — Deutsche Bank reiterated Buy with a $495 target in a note published Dec. 12.
  • Jefferies: Buy, $535 target — Jefferies reiterated Buy and maintained a higher target versus many peers, based on MarketScreener’s report.
  • Mizuho: Outperform, target cut to $495 (from $520) — Mizuho lowered its target while maintaining Outperform, citing market/peer multiples after management sessions.

What this means for investors: The overall picture is not “analysts turning bearish.” It’s more nuanced: targets are being recalibrated lower, but many firms still see a path to meaningful upside if Linde executes and macro conditions stabilize. Investing.com

2) Where price targets and “consensus” sit right now

Across widely circulated summaries, the Street’s target range remains wide—reflecting disagreement about how quickly industrial volumes recover and how much premium Linde deserves post-reset.

  • Investing.com’s recap of the UBS note referenced a target range roughly $381 to $565 and described the broader consensus stance as bullish.
  • MarketBeat’s snapshots currently show an average target around $501 with a “Buy” consensus in its dataset. MarketBeat
  • A Nasdaq/Fintel syndicated note cited an average one‑year price target above $500 (with a wide low-to-high range), reinforcing how dispersed forecasts remain.

Forecasts that matter most: EPS trajectory, not just near-term headlines

Linde’s own guidance anchors the debate

The most important hard-number “forecast” in the market is still the company’s guidance, most recently reiterated alongside Q3 results:

  • Q4 2025 adjusted EPS guidance:$4.10 to $4.20
  • Full‑year 2025 adjusted EPS guidance:$16.35 to $16.45

That Q4 range drew attention because it came in below the analysts’ mean estimate cited by Reuters at the time, and management pointed to Europe volume weakness as a key headwind.

Analyst “algorithm” vs. macro reality

The push-and-pull in current analyst commentary is essentially this:

  • Bull case: Linde’s pricing discipline, productivity, and capital allocation (capex + backlog + buybacks) can keep EPS compounding at a high rate even in a muted macro environment.
  • Cautious case: Europe remains soft enough that the market is reluctant to pay peak multiples; some firms trimmed targets and EPS models accordingly.

Fundamentals recap: what Linde reported in Q3 2025 (and why it still shapes the stock)

Linde’s latest reported quarter remains central to the story because it demonstrated resilience despite “stagnant industrial activity,” while also highlighting where demand is still under pressure.

From Linde’s Q3 2025 release:

  • Net income: $1.929 billion; adjusted EPS: $4.21
  • Sales: $8.615 billion (up 3% year over year)
  • Adjusted operating margin: 29.7%
  • Operating cash flow: $2.948 billion; free cash flow: $1.672 billion
  • Capital return: $1.685 billion returned via dividends and net repurchases during the quarter
  • Capex outlook: Full‑year capex expected at $5.0–$5.5 billion, tied to growth + maintenance and supported by a $7.1 billion contractual sale-of-gas project backlog

On the macro side, Reuters reported that volume sales fell in Linde’s Europe/Middle East/Africa region and that management expected that trend to continue, reflecting broader European industrial weakness.


“Follow the filings”: liquidity and capital structure updates investors are citing

$1.5 billion 364‑day revolving credit agreement (Dec. 3 filing)

One of the more concrete corporate updates close to mid‑December is a U.S. SEC filing describing a new short‑term revolving facility:

  • Linde and subsidiaries entered an unsecured 364‑day revolving credit agreement with $1.5 billion in commitments, usable for general corporate purposes, with multi‑currency borrowing options.
  • The filing stated there was no usage outstanding as of the report date.

Linde’s own financing page also summarizes that it has a $5.0B revolving facility (maturing in Dec. 2027) and a $1.5B 364‑day facility expiring in Dec. 2025, both described as fully undrawn, alongside a $6.5B commercial paper program.


Dividend update: Dec. 17 payment date

Income investors have another near-term catalyst on the calendar: Linde declared a quarterly dividend of $1.50 per share, payable December 17, 2025, to shareholders of record December 3, 2025.


Insider activity: CEO purchase drew attention in early December

A closely watched signal in the past week has been insider buying: reporting tied to a Form 4 filing indicates CEO Sanjiv Lamba purchased 2,520 shares on Dec. 8, 2025 at a weighted average price around $396.68, worth roughly $1.0 million.

Insider buys don’t guarantee anything—but they often become part of the narrative when a stock is trading well below recent highs.


Institutional activity: the “quiet” Dec. 14 news flow

Because Dec. 14, 2025 falls on a Sunday, part of the newest headline stream is made up of automated recaps of institutional ownership filings.

For example, MarketBeat published pieces dated Dec. 14, 2025 summarizing changes in institutional positions (e.g., HRT Financial and Orion Portfolio Solutions), alongside a reminder that institutional ownership remains high and that analyst consensus in its dataset is “Buy.” MarketBeat

For long-term investors, these filings are usually context, not catalyst—but they do reinforce that Linde remains widely held across major funds.


The big debate heading into 2026: “premium compounder” or “macro-limited multiple”?

To understand why Linde stock has been volatile into year-end, it helps to frame the core question analysts are trying to answer:

Why bulls still like Linde

  • Contracted backlog and project ramp profile: Linde’s contractual sale-of-gas backlog is measured in the billions, and multiple analysts argue 2026 could see meaningful project contributions as large facilities come online.
  • Capital allocation discipline: Management emphasizes a repeatable model—pricing, productivity, disciplined capex and buybacks—that supports EPS compounding.
  • “Quality at a reset valuation” narrative: Some analysts and financial media have highlighted that the late‑2025 pullback improved the valuation setup versus earlier in the year. Investing.com UK

What skeptics (or cautious bulls) are watching

  • Europe industrial weakness: This remains the most frequently cited macro pressure point in recent company/Reuters coverage and in target cuts.
  • Multiple compression risk: Even strong businesses can underperform if investors decide they should no longer trade at a large premium during a slow cycle—an idea explicitly discussed in the “valuation reset” framing. Investing.com UK

What to watch next for Linde (LIN) stock

As 2025 closes, the near-term checklist for Linde investors is fairly straightforward:

  1. Any update on industrial volumes—especially EMEA (the region cited as weak in recent guidance commentary).
  2. Project execution and backlog conversion into 2026 revenue/EPS contributions.
  3. Capital returns and balance-sheet flexibility, including the revolving facilities described as fully undrawn and the continued cadence of dividends.
  4. Analyst revisions: after the December round of target resets, further changes will likely be tied to macro data and management’s next formal outlook update.

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors. Follow Khadija Saeed on Google News.

Google Preferred Source

TS2 Tech on Google

Follow the stories that move markets

Make TS2 Tech a preferred source or open our publication directly in Google News.

TS2 TECH • DAILY MODEL PORTFOLIO

Stocks to Buy Today

Five stocks stand out, supported by recent earnings or more attractive entry points. Today's selection highlights companies raising their outlooks and reporting firm orders, rather than focusing on heavily traded chipmakers.

Today’s market stance Selective • earnings-led
#1 • HIGHEST CONVICTION 24% weight

Xylem

NYSE: XYL
STRONG BUY
Model score 92 / 100
★★★★★

A 12-cent earnings beat and raised 2026 profit outlook highlight the results, while quarterly revenue matched expectations. The water treatment segment offers AI infrastructure exposure without increasing semiconductor holdings.

Why today

Earnings per share surpassed expectations; the company raised its guidance, citing increased water demand from data centers.

Next catalyst

Order conversions are being monitored to confirm that the new margin level is sustainable.

Main risk: Annual revenue guidance moved to about $9.2bn, and project timing can shift.
#2 • BEST CONTRARIAN 22% weight

Alphabet

NASDAQ: GOOGL
BUY ON WEAKNESS
Model score 89 / 100
★★★★½

Google Cloud's revenue surged 82%, with its operating margin hitting 35.6%. However, shares declined as capital expenditures increased. The reset offers a better entry point, but exposure remains limited since quarterly free cash flow moved into negative territory.

Why today

Cloud segment outperformed expectations; company reset guidance following earnings; search operations continue to drive strong cash flow.

Next catalyst

Cloud backlog is being converted more efficiently, leading to improved alignment between expenditures and cash flow.

Main risk: 2026 capex is now $195bn to $205bn, while depreciation is rising.
#3 • DEFENSIVE GROWTH 20% weight

Unilever

LON: ULVR • NYSE: UL
BUY ON PULLBACKS
Model score 87 / 100
★★★★☆

Underlying sales increased by 5.8%, driven by a 5.5% rise in volume—the company's strongest volume growth in over ten years. Guidance has been raised, but after today's significant share price jump, a gradual approach to buying may be more prudent.

Why today

Strong volumes drive results; outlook raised; steady cash flow in low-beta environment

Next catalyst

Second-half pricing trends and updates on the Foods transaction.

Main risk: Commodity inflation, currency moves and a large one-day gap.
#4 • EARNINGS MOMENTUM 18% weight

Sherwin-Williams

NYSE: SHW
ACCUMULATE
Model score 84 / 100
★★★★☆

Sales and adjusted earnings surpassed expectations, prompting management to raise its full-year guidance. The company is benefiting from higher prices and increased market share, but the stock's rapid three-day rally suggests investors may want to hold off on buying at the open.

Why today

The company beat expectations, raised its outlook, demonstrated strong pricing power, and continued to gain market share.

Next catalyst

The company is targeting adjusted EPS between $11.80 and $12.20.

Main risk: Weak housing demand, raw-material inflation and a richer entry.
#5 • TACTICAL UPSIDE 16% weight

PayPal

NASDAQ: PYPL
TACTICAL BUY
Model score 81 / 100
★★★★☆

Adjusted earnings surpassed expectations, prompting an increase in full-year profit guidance. The reported $60.50 per share approach offers added flexibility, though its smaller weighting signals lower margins and uncertainty regarding a potential deal.

Why today

Earnings surpass forecasts; guidance raised; strategic options under review.

Next catalyst

Focus is on the $400 million cost program, margin trends, and any official response to the deal.

Main risk: Operating margin fell to 17.4%, and no sale is assured.
Portfolio structure
Water & infrastructure 24%
Technology & cloud 22%
Consumer staples 20%
Coatings & materials 18%
Payments 16%
Build positions in two or three tranches.

Avoid buying a stock that's trading more than 5% above its previous close. Revisit the list after Wednesday's Fed decision and this week's mega-cap earnings.

Strong companies, weaker entries today
Coca-Cola NYSE: KO
WAIT FOR PULLBACK

Strong quarter with improved guidance, but a nearly 6% rally limits short-term upside.

Visa NYSE: V
WAIT FOR RESULTS

Visa is set to report earnings after the close. The portfolio won’t be taking on new event risk ahead of the results.

Nvidia NASDAQ: NVDA
WATCH

While long-term demand is solid, questions persist around chip momentum and AI financing.

Portfolio heat 6.4 / 10

Moderate. Recent earnings provide solid support, though event risk is still elevated.

Market risk check

The Nasdaq faces continued pressure as chip stocks endure a steep correction. With the Federal Reserve set to announce its decision on Wednesday, investors should brace for increased intraday volatility.

TS2 DAILY MODEL PORTFOLIO 100% allocated

This is an editorial model portfolio and does not constitute personalized investment advice. The scores reflect how today's five holdings compare to the current opportunity set, rather than predicting future returns.

Eli Lilly Stock (LLY) News, Forecasts and Analyst Outlook — Retatrutide Breakthrough, Orforglipron FDA Timeline, and a $6B Manufacturing Bet (Dec. 14, 2025)
Previous Story

Eli Lilly Stock (LLY) News, Forecasts and Analyst Outlook — Retatrutide Breakthrough, Orforglipron FDA Timeline, and a $6B Manufacturing Bet (Dec. 14, 2025)

Fermi Inc. (FRMI) Stock News Today: $150M Funding Deal Terminated, Project Matador Updates, and Analyst Price Targets (Dec. 14, 2025)
Next Story

Fermi Inc. (FRMI) Stock News Today: $150M Funding Deal Terminated, Project Matador Updates, and Analyst Price Targets (Dec. 14, 2025)